All In Biotech

Drug Trial Radar · NCT05029050

Dexmedetomidine or Clonidine Infusion for Prevention of Delirium After Open Heart Surgery

Alpha 2 Adrenergic Receptor Agonists for the Prevention of Delirium and Cognitive Decline After Open Heart Surgery (ALPHA2PREVENT): Randomised Controlled Trial.

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 900 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

900

Planned (sponsor's estimate)

Start

Jan 17, 2022

Primary completion

Jul 31, 2026

Study completion Jan 2027

Sponsor

Lead sponsor
Oslo University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Haukeland University Hospital; University Hospital of North Norway; UMC Utrecht; Sahlgrenska University Hospital; St. Olavs Hospital
First posted
Aug 31, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A parallel-group treatment, five-centre, participant and investigator masked, three-arm study to assess the safety and effectiveness of dexmedetomidine or clonidine infusion compared to placebo for the prevention of delirium and cognitive decline in male and female participants aged 70+ scheduled for open heart surgery.

Conditions

  • Delirium
  • Cognitive Decline
  • Frailty

Interventions

  • DexmedetomidineDrug

    Continous intravenous infusion

  • ClonidineDrug

    Continous intravenous infusion

  • NatriumchloridDrug

    Continous intravenous infusion NaCl

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Postoperative deliriumTime frame: Up to 7 days

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Haukeland University Hospital

    Bergen, Norway

  • Oslo University Hospital Rikshospitalet

    Oslo, Norway

  • Oslo University Hospital Ullevål

    Oslo, Norway

  • University Hospital of North Norway

    Tromsø, Norway

  • St Olav University Hospital

    Trondheim, Norway

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.